Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation
about
The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?New B7 Family Checkpoints in Human Cancers.The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation.
P2860
Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Dies1/VISTA expression loss is ...... r due to epigenetic regulation
@en
type
label
Dies1/VISTA expression loss is ...... r due to epigenetic regulation
@en
prefLabel
Dies1/VISTA expression loss is ...... r due to epigenetic regulation
@en
P2093
P2860
P50
P356
P1433
P1476
Dies1/VISTA expression loss is ...... r due to epigenetic regulation
@en
P2093
David Huntsman
Mafalda Azevedo
Sara Rocha
Sofia Valente
P2860
P2888
P356
10.1038/SREP34860
P407
P50
P577
2016-10-10T00:00:00Z